Preferences for Attributes of Medications among Patients with Type 2 Diabetes: A Cross-Medication Class Comparison of Injection Therapies

Jiat Ling Poon, Kristina S Boye, Vivian T Thieu, Kirsi Norrbacka, Syed W Hassan and Heather L Gelhorn
Additional contact information
Jiat Ling Poon: Eli Lilly and Company, USA
Kristina S Boye: Eli Lilly Finland, Finland
Vivian T Thieu: Eli Lilly Finland, Finland
Kirsi Norrbacka: Eli Lilly Finland, Finland
Syed W Hassan: Eli Lilly Finland, Finland
Heather L Gelhorn: Evidera, Bethesda, USA

Current Research in Diabetes & Obesity Journal, 2018, vol. 6, issue 5, 92-104

Abstract: Purpose: To use a discrete choice experiment (DCE) to determine patient preferences for the treatment features of dulaglutide 1.5mg vs insulin glargine (SoloSTAR®) among people with type 2 diabetes mellitus (T2DM) naïve to injectable diabetes therapy, in the United Kingdom (UK).

Keywords: juniper publishers; diabetes journals; diabetes impact factor; endocrinology journal; endocrinology impact factor; endocrinology research journal; endocrinology research articles; diabetes open access journals; Obesity Journal; Diabetes & Obesity Journal (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/crdoj/pdf/CRDOJ.MS.ID.555700.pdf (application/pdf)
https://juniperpublishers.com/crdoj/CRDOJ.MS.ID.555700.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jcrdoj:v:6:y:2018:i:5:p:92-104

DOI: 10.19080/CRDOJ.2018.06.555700

Access Statistics for this article

Current Research in Diabetes & Obesity Journal is currently edited by Sophia Mathis

More articles in Current Research in Diabetes & Obesity Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().